478148-60-6

Basic information

• Product Name: Furo[2,3-c]pyridine-5-methanol (9CI)
• Synonyms: Furo[2,3-c]pyridine-5-methanol (9CI);furo[2,3-c]pyridin-5-ylmethanol;Furo[2,3-c]pyridine-5-Methanol
• CAS NO: 478148-60-6
• Molecular Formula: C₈H₇NO₂
• Molecular Weight: 149.14668
• Product Categories: PYRIDINE
• Mol File: 478148-60-6.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 289.84 °C at 760 mmHg
• Flash Point: 129.091 °C
• Appearance: /
• Density: 1.315 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.36±0.10(Predicted)
• CAS DataBase Reference: Furo[2,3-c]pyridine-5-methanol (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Furo[2,3-c]pyridine-5-methanol (9CI)(478148-60-6)
• EPA Substance Registry System: Furo[2,3-c]pyridine-5-methanol (9CI)(478148-60-6)

Safety Data

• Hazardous Substances Data: 478148-60-6(Hazardous Substances Data)

Usage

General Description

Furo[2,3-c]pyridine-5-methanol (9CI) is a chemical compound with the molecular formula C7H7NO. It is a member of the furo[2,3-c]pyridine family, which is a fused heterocyclic ring system. Furo[2,3-c]pyridine-5-methanol (9CI) is a secondary alcohol with a furo[2,3-c]pyridine ring attached to a hydroxyl group. Furo[2,3-c]pyridine-5-methanol (9CI) has potential applications in the pharmaceutical industry, particularly in the development of novel drug molecules due to its unique structural features. It may also have uses in organic synthesis and chemical research.

Upstream product

• 952587-20-1 {5-hydroxy-4-[(trimethylsilyl)ethynyl]-2-pyridinyl}methyl acetate trifluoroacetate 
• 952587-18-7 {5-({[4-(methyloxy)phenyl]methyl}oxy)-4-[(trimethylsilyl)ethynyl]-2-pyridinyl}methyl acetate 
• 724788-78-7 (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate 
• 441044-90-2 [7-chloro-2-(trimethylsilyl)furo[2,3-c]pyridin-5-yl]methanol 
• 478148-59-3 5-hydroxymethyl-2-trimethylsilyl-furo[2,3-c]pyridine 
• 208519-38-4 2-chloro-6-(hydroxymethyl)-4-[(trimethylsilyl)ethynyl]-3-pyridinol 
• 208519-37-3 2-chloro-3-hydroxy-6-(hydroxymethyl)-4-iodopyridine 
• 208519-41-9 2-chloro-6-(hydroxymethyl)-3-pyridinol 
• 6636-78-8 2-chloro-3-hydroxypyridine 
• 956010-20-1 [2-(trimethylsilyl)furo[2,3-c]pyridin-5-yl]methyl acetate 
• 478149-20-1 furo[2,3-c]pyridin-5-yl methyl acetate 
• 208519-39-5 (7-chlorofuro[2,3-c]pyridin-5-yl)methanol 

Downstream Products

• 944407-44-7 2H,3H-furo[2,3-c]pyridin-5-ylmethanol 
• 872715-05-4 2,3-dihydrofuro[2,3-c]pyridine-5-carbaldehyde 
• 478148-61-7 furo[2,3-c]pyridine-5-carbaldehyde 
• 478149-53-0 PHA-543613 
• 478148-62-8 furo[2,3-c]pyridine-5-carboxylic acid 

Relevant articles and documents

CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER

[Object] It is to provide a novel LXRβ agonist useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A carbinol compound represented by the following general formula (I) or salt thereof, or their solvate: (wherein, each V and W independently show N or C—R7; each X and Y independently show CH2, C═O, SO2, etc; Z shows CH or N; each R1, R2 and R7 independently show a hydrogen atom, C1-8 alkyl group, etc.; R3 shows C1-8 alkyl group; R4 shows an optionally substituted C6-10 aryl group or an optionally substituted 5- to 11-membered heterocyclic group; R5 and R6 show a hydrogen atom, etc.; L shows a C1-8 alkyl chain optionally substituted with an oxo group, etc.; and n shows any integer of 0 to 2.)

DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES

Bicyclic nitrogen containing compounds and their use as antibacterials.

Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis

Tricyclic nitrogen-containing compounds of Formula (I) and pharmaceutically acceptable derivatives thereof: compositions containing them, their use in the treatment of tuberculosis, and methods for the preparation of such compounds.